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ABSTRACT 
Hernia repair is one of the most common operations in general surgery, and its 
associated complications typically relate to infections, among others. The loading of 
antibiotics to surgical meshes to deliver them locally in the abdominal hernia repair site 
can be one way to manage infections associated with surgical implants. However, the 
amount of drug loaded is restricted by the low wettability of polypropylene (PP). In this 
work, plasma has been used to tailor the surface properties of PP meshes to obtain high 
loading of ampicillin while conserving the desired biological properties of the 
unmodified samples and conferring them with antibacterial activity. It was 
demonstrated that the new surface chemistry and improved wettability led to 3-fold 
higher antibiotic loading. Subsequently, a PEG-like dry coating was deposited from 
tetraglyme with low-pressure plasma which allowed maintaining the high drug loading 
and kept cell properties such as chemotaxis, adhesion and morphology to the same 
levels as the untreated ones which have shown long-standing clinical success.  




In the past decade, polypropylene (PP) meshes have been used as prosthetic 
biomaterials not only to buttress the defect of incisional hernias, abdominal or inguinal, 
creating a tension-free repair [1-4] but also for the treatment of stress urinary 
incontinence [5], for vaginal prolapse [6] or to prevent prosthetic device infection [7]. 
Abdominal hernia is the protrusion of intra-abdominal content through the abdominal 
wall [1] from which around 1 million patients in the USA alone undergo repair surgery 
[8]. It has been shown that there are major physico-chemical differences between 
available meshes, which, in combination with the location of the mesh, the surgical 
technique applied and hernia type involved influence the infection potential [1]. 
Prosthetic device infection is a broad problem that can occur at varied stages of the 
materials lifespan and can be acute or delayed in their presentation [9]. The nature of 
device infections requires both preventive and therapeutic strategies. One of the current 
approaches to prevention includes the use of prophylactic preoperative systemic 
antibiotics. This approach should achieve adequate local tissue antimicrobial levels to 
fight the infection but comes at the risk of systemic effects secondary to the antibiotic 
exposure [7]. Several studies have shown the benefits of different kinds of antibiotics 
(such as cefazolin, ampicillin/sulbactam, amoxicillin or ampicillin/clavulanic acid) in 
the prevention of postoperative surgical site infection after inguinal PP mesh hernia 
repair [10-13]. However, as highlighted in the review by Bratzler et al. [10], randomized 
controlled trials have failed to identify an agent that is clearly superior to other agents 
for surgical site infection prophylaxis in hernia repair. 
In recent developments, the focus has turned to improve surgical meshes incorporating 
cyclodextrin and maltodextrin for the prolonged release of ciprofloxacin from a PP 
artificial abdominal wall implant [14] or a degradable polycaprolactone/polylacide 
multilayer coating obtained by spraying onto PP as a carrier for the sustained release of 
oxofloxacin and rifampicin [15]. However, PP has low wettability and adhesion, 
impairing the loading of molecules directly in the polymer. Thus, Nistico et al. pre-
treated PP meshes with atmospheric pressure plasma dielectric barrier discharge to 
enhance the surface adhesion of the biopolymer chitosan which has antibacterial 
properties itself [16].  
Plasma treatment of polymer substrates has been commonly employed to tailor surface 
adhesion and wetting properties by changing the surface chemical composition [17-20]. 
Broadly, the plasma state can be considered as a gaseous mixture of a number of active 
species, including oppositely-charged particles that preserve electrical charge neutrality 
[21]. Appropriate selection of the plasma source enables the introduction of diverse 
functional groups on the target surface to improve wettability, biocompatibility or to 
allow subsequent covalent immobilization or physical adsorption of various molecules 
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such as dyestuffs [22], pharmaceutical or cosmetic active principles [23-24]. Plasma can 
also be used for the deposition of thin polymer films by the so-called plasma 
polymerization process. Coating by plasma polymerization is defined as the formation 
of thin polymer coatings, on a surface such as a polymeric biomaterial, under the 
influence of plasma conditions [25, 26]. By modifying the process parameters and the 
precursor molecule, different kinds of biocompatible coatings can be produced, from 
cell-adhesive coatings to antifouling coatings. 
The aim of the present work is to obtain antibiotic-loaded PP meshes with enhanced 
drug loading on the materials while preserving their biological behavior using a novel 
approach by combining different plasma processes. Thus, plasma surface 
functionalization of PP meshes is investigated to increase the potential amount of 
ampicillin loading. As the expected wettability enhancement produced by plasma may 
modify the biological behavior of the material, low pressure plasma polymerization 
with a PEG-like precursor was examined to obtain a thin layer of polymer on the 
surface through a dry method.  To understand better the processes, the physicochemical 
material properties were studied at different stages of treatment along with material 
performance of drug release, antibacterial activity and cell adhesion.  
2. EXPERIMENTAL PART
1. Materials
A polypropylene surgical knitted mesh, made from a 0.15 mm diameter monofilament, 
with 1.3 x 1.0 mm pore size and 97.0 ± 2.0 g/m2 weight, (SurgicalMeshTM, USA) was 
selected for this research. For contact angle measurements a PP film (Goodfellow) was 
used as a model surface. To avoid the potential influence of the additives used during 
polypropylene manufacture on the wetting properties of the materials, we prepared the 
surface of both materials by washing following the same protocol [24]. 
Ampicillin sodium salt (371.39 g/mol), provided by Sigma Aldrich® was selected for 
incorporation in the PP mesh, and presents a water solubility of 50 mg/mL.  
Tetraetylene glycol dimethyl ether (tetraglyme, Sigma Aldrich) CH3O(CH2CH2O)4CH3) 
was used as precursor for plasma polymerization. Phosphate buffer saline (PBS), pH 
7.4, was prepared from KH2PO4 (Fagron Iberica S.A.V, Spain), Na2HPO4 (Probus S.A, 
Spain), NaCl (Acofarma®, Spain), and Milli-Q® deionized water. All chemicals used 
were of analytical grade. Orthophosphoric acid (H3PO4), 85% purity, from Scharlab 
S.L. (Spain) was used to adjust the pH value of the phosphate buffer solution. 
Agar bacteriological (Scharlau S.A., Spain) and Brain Heart Infusion Broth (BHI Broth) 
(Scharlau S.A., 02-599, Spain) were used to prepare the bacteriological culture media of 
Staphilococcus aureus and Escherichia coli. 
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2. Plasma surface functionalization
Plasma functionalization treatments (F-) at atmospheric pressure were carried out by 
means of an Ahlbrandt FG-2 (Germany) corona plasma using air as the plasma forming 
gas. The distance between the electrode and the fabric was adjusted to 10 mm. During 
the treatments, power, speed and discharge current were kept constant at 380 W, 15 
r.p.m. and 1.90 A respectively. Fabrics were treated for 1.05 s, 1.75 s, 3.5 s and 7.0 s 
(samples are coded as F-1.05s, F-1.75s, F-3.5s, F-7s) (Fig. 1).  
To minimize the ageing process of all plasma-treated samples [27-29], analysis and 
post-treatments (including fabric loading) were carried out immediately following 
plasma treatment of the fabrics. 
3. Plasma polymerization coatings
Plasma polymerization of polyethylene glycol (PEG) was carried out with low-pressure 
radio-frequency plasma (13.56 MHz) (Standard Femto Plasma System, Diener, 
Germany), by introducing tetraglyme in the plasma chamber by bubbling a carrier gas 
(argon) through liquid tetraglyme. Polymerization treatment was performed at 0.4 mbar 
for 2 hours at an average power of 200 W; the plasma was pulsed with a pulse width of 
20 μs with 20 ms between pulses. Before polymerization, a short surface activation step 
was carried out with argon, at 0.40 mbar of pressure for 30 s at 100 W.  
4. Antibiotic loading of PP meshes
Polypropylene meshes were cut into rectangular samples of (7.0×5.0) cm, weighing 
approximately 0.32 g each. Loading of the PP samples was carried out by immersion in 
a 4% ampicillin solution in distilled water at a fabric/bath relation of 1/10, during 24 h 
with continuous shaking at 160 r.p.m. at 20 ˚C. Subsequently, PP samples were 
submitted to a double padding process under 1 kg/cm2 pneumatic pressure and 1 m/min 
speed working conditions. Samples were finally dried in an oven during 24 hours at 37 
˚C. The samples were weighed before and after the loading process to calculate the 
amount of caffeine in the fibres and the loading ratio. A minimum of 4 replicates were 
done for each kind of sample.  
5. In vitro release assays
Drug release assays were adapted from the USP dissolution test [30]. Five thermo-
stabilized vessels were filled with 300 mL of PBS (pH 7.4), the stirring rate and 
temperature were maintained at 25 r.p.m. and 37 ºC respectively, during the 4 hours of 
the release experiment. The PP meshes were placed on a vertical stainless steel holder 
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that ensures optimum contact between the textile materials and the buffer solution. 1 
mL samples were withdrawn from the receptor compartment for latter spectroscopy 
analysis [23]. After each sample withdrawal, the same volume of fresh PBS was added 
to the receptor medium. Sink conditions were kept constant in the receptor solution 
during the experiment [31]. 4 replicates of antibiotic-loaded PP with the different 
treatments were studied, together with an un-loaded mesh used as a reference.  
6. Surface topography analysis
Topography of the untreated and plasma treated PP meshes was studied by Field-
Emission Scanning Electron Microscopy using a Jeol JSM 5000 SEM. All samples were 
Au coated prior to SEM observation. Observations were carried out at 15 kV working 
voltage.  
Atomic Force Microscopy (AFM) was performed with a Solver PRO 47 (NT-MDT, 
Moscow, Russia). Oscillating semicontact mode with Si cantilever (NSG 10 from NT-
MDT, Moscow, Russia) with a typical force constant of 11.8 Nm-1, operating at a 
typical resonance frequency of 240 kHz was used for surface imaging over range 1×1 to 
20×20 μm2. Surface roughness Ra was calculated as the mean of the average surface 
roughness after subtraction of the background from the image. 
7. Static contact angle
A Krüss DSA100 goniometer was used for the acquisition of the measures. Due to the 
difficulty of measuring contact angle on the fibres, a PP film was used as a model 
surface. Untreated (UT) and plasma-treated PP films were laid flat on a glass support 
and 10 μL water droplets were deposited on the film. Measurements were carried out on 
the plasma-treated side of the samples. In this study, 5 replicates of each measurement 
were carried out. 
8. X-Ray Photoelectron Spectroscopy (XPS)
X-ray Photoelectron Spectroscopy analysis of the PP meshes was performed in a XPS 
Spectrophotometer TFA XPS (Physical Electronics Inc., Chanhassen, Minnesota, USA). 
An Al monochromatic source of X-ray light with a power of 250 W was used. The 
relative error for XPS determination is about 0.5㸣. Each sample was analyzed at two 
different places and the average composition was calculated. In addition to the wide 
energy range spectra, high-energy resolution spectra of characteristic peaks of C1s, O1s, 
N1s and Si2p elements are recorded through a narrow energy range. Spectra were 
referenced to the C1s peak, at 284.80 eV [32].  
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9. Cell cultures
9.1.  Cell lines 
Cell lines used in this study were purchased from the American Tissue Type Culture 
Collection (ATCC) [33]. Studies were performed using two mammalian cell lines 
(purchased from ATCC/LGC Standards, Spain); human monocyte THP-1 (TIB-202), 
and mouse fibroblast NIH/3T3 (CRL-1658). THP-1 monocytes were grown in RPMI 
medium 1640 (Gibco/Life-Technologies, Spain), supplemented with 10% FBS (Thermo 
Fisher Scientific, Spain), 100 U/ml penicillin, 100 μg /ml streptomycin sulfate, and 2 
mM L-glutamine (Gibco/Life-Technologies, Spain). NIH/3T3 fibroblasts were 
propagated in Dulbecco's Modified Eagle Medium (DMEM; Gibco/Life-Technologies, 
Spain) with 2 mM L-glutamine supplemented with 10% fetal bovine serum (FBS), 100 
U/ml penicillin G and 100 μg/ml streptomycin. Cells were maintained at 37 °C in a 
humidified atmosphere of 5% CO2. 
9.2.  Preparation of conditioned media 
Sterile-packaged meshes (gamma sterilized at 8 kGy) were always processed under a 
sterile laminar flow hood. Upon receipt, the material was cut and rinsed in 0.1 M PBS, 
pH 7.4. The resulting fragments were added to a complete cell growth medium without 
antibiotic (2 cm2 mesh/mL medium) containing 2% or 10% FBS depending on the assay 
used, and placed in an incubator for the specified time at 37 ºC, 5% CO2. Afterwards, 
the conditioning PP material was removed and the media was collected and passed 
through a 0.20 μm filter unit (Millipore). Additional control medium was processed 
simultaneously.  
9.3. Proliferation and viability assays 
Cell viability behavior of the meshes was evaluated using conditioned media-treated 
THP-1 human monocytes and NIH-3T3 mouse embryonic fibroblast cells. THP-1 cells 
were plated at an initial density of 1×105 cells/ml in 24-well dishes (0.5 mL/well) in 
mesh-conditioned medium. At 24, 48 and 72 h after plating, cell density was determined 
using a cell counter (Z™ Series Coulter Counter®, Beckman Coulter, Barcelona, 
Spain). The percent growth was calculated according the following equation:  
% cell growth = ((final cell density – initial cell density) / initial cell density) × 100 
Trypan blue dye exclusion staining was also performed to assess cell viability. 
A suspension of NIH/3T3 cells was used to seed 1×104 cells in 0.5 mL of complete 
medium (w/o antibiotics) /chamber in 24-well dishes. After overnight incubation under 
standard conditions, the culture supernatants were aspirated, and each well was rinsed 
with 0.1 M PBS before being supplied with 0.5 mL of mesh-conditioned medium. After 
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incubation for 24 and 48 hours, cells were gently washed with 0.1 M PBS (×3). Cells 
remaining on the bottom surface were fixed (ice-cold 100% methanol, 10 min) and 
stained (0.5% crystal violet solution in 25% methanol, w/v, 15 min). The plate was 
gently washed and once dried, cells were observed under an inverted bright-field 
microscope. After that, crystal violet was dissolved in 1% SDS solution and analyzed by 
spectrophotometry (OD 590 nm).  
9.4.  Chemotaxis assay 
The chemotactic migration response to conditioned media was assessed in NIH/3T3 
fibroblasts using 6.5 mm Transwell® migration devices (8 μm-pore polycarbonate 
membrane, Corning, Lowell, MA, USA) following supplied instructions. Cells (1×105 
cell/ml) were plated in DMEM supplemented with 2% FBS (v/v) into the upper 
chamber and incubated at 37 °C, 5% CO2. The lower chamber was filled with 
conditioned and control media (both using DMEM with either 2% or 10% (v/v) FBS). 
Twenty-four hours later, non-migrated cells were scraped off of the filter’s upper 
surface. The insert was removed and stained with crystal violet as explained above to 
quantify cells migrating through the filter and remaining attached to its lower side for 
each well. Chemotactic index was calculated as the ratio of cell migration toward 
conditioned media divided by cell migration toward media alone. 
9.5.  Cell adhesion 
Cell attachment on each substrate was evaluated by recording the number of NIH/3T3 
fibroblasts attached after 24 h of incubation. Meshes were fixed in 12-well dishes using 
CellCrownTM inserts (Scaffdex, Sigma-Aldrich, Madrid, Spain) over a non-adhesive 
agarose layer (0.9%) polymerized in the bottom of each well. A number of 1×105 
cells/well were seeded onto the materials. After incubation, the specimens were washed 
with D-PBS (3×) to eliminate unattached cells and the adherent cells were stained with 
crystal violet and photographed using bright-field microcopy. The results were 
expressed as the number of adherent cells per unit surface of the material (counts in 10 
fields per condition). 
10. Antibacterial assays
The antibacterial activity of the treated meshes was tested against Staphylococcus 
aureus (S. aureus) CCUG 15915 and Escherichia coli (E. Coli) CCUG 10979 and 
(Culture Collection University of Göteborg (CCUG), Göteborg, Sweden). To 
qualitatively determine the antibacterial activity on the treated textile materials the 
Parallel Streak Method AATCC Test Method 147-2004 was used. This method consists 
of placing several parallel streaks in a standard Petri dish with the appropriate culture 
media for the bacteria tested, in this case Brain Heart Infusion Broth (BHI Broth) 
(Scharlau S.A., 02-599, 500 g, lot 10227) at [BHI] = 37.0 g.L-1. 
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3. RESULTS
3.1.  Influence of plasma treatment on the surface chemistry of the PP mesh 
The behavior of the static water contact angle on the untreated (UT) and plasma 
functionalized (F) PP film - used as a model surface for the PP fibres - is shown in Fig. 
2. It can be observed that the UT PP film, with a contact angle of 124.4 °, has a clear
hydrophobic character. Whereas when it is treated with air plasma, under any of the 
experimental conditions tested, it acquires hydrophilic properties, showing contact 
angles below 90 °. It can be observed that contact angle shows an exponential decrease 
as a function of F plasma treatment time and thus wettability is significantly improved 
in all cases. A plateau is reached at approximately 25 º after 3.5 s of treatment. 
It can also be observed that the plasma polymerization treatment of Tetraglyme using 
argon as carrier gas to create PolyEthyleneGlycol coatings (PEG) additionally modifies 
the wettability of PP. After the plasma polymerization treatment, the wettability of UT 
PP dropped significantly (46.5%). The same treatment on the F-3.5s+PEG plasma 
treated sample led to superhydrophilic properties, with contact angle of 0 º. 
Table 1 details the elemental relative composition of the fibre surface of UT, F-plasma 
and PEG plasma coated PP meshes. The untreated PP mesh presents a surface 
composition with 84% of C1s and 10% of O1s. After F air plasma of the PP meshes, a 
progressive increase of oxygen groups combined with a reduction of silicon is recorded.  
In Fig. 3, the C1s high resolution XPS spectra of the UT, F-3.5s plasma-treated and PEG 
plasma-polymerized PP meshes are presented. It can be observed that the C-C and C-H 
bonds are predominant for the UT PP mesh (97.7%) since the structure of PP includes 
only these atoms and type of bonding. Submitted to F air plasma treatment, the PP 
fibres undergo a progressive functionalization process of the fibre surface by O atoms 
through C-O bonds with the plasma treatment time up to 6.8% for 3.5 s of plasma 
treatment (F-3.5s). The C1s peak decomposition of the PEG coated samples also 
revealed the introduction of C=O and COOH functional groups on the surface of 
polypropylene.  
3.2.  Influence of plasma treatment on the loading and release of ampicillin 
The ampicillin loading percentage of F plasma-treated PP meshes at different treatment 
times is presented in Fig. 4. UT PP presents low drug loading of only 20.8%. With the 
increase of F plasma treatment time, loading progressively improves up to 59.5% for an 
air plasma treatment time of 3.5 s (F-3.5s). Longer plasma treatment times (F-7s) do not 
lead to a further improvement of the ampicillin loading, in parallel to the wetting 
behavior of plasma-treated PP. 
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After ampicillin loading of the UT or F plasma-treated PP meshes, plasma 
polymerization was performed with tetraglyme to produce a thin PEG coating on the 
surface by means of a dry method. The total percentage of ampicillin released from the 
different PP meshes is shown in Fig. 5.  
While the UT PP mesh presents an ampicillin release of 74.7%, F-plasma treated PP 
fibres show slightly higher ampicillin release from the PP meshes, reaching values of 
84.6% for F-3.5s plasma-treated PP fibres without modification of the release kinetics 
with respect to the untreated mesh (burst release pattern was found in all cases – data 
not shown). UT+PEG-coated PP meshes display lower release values. Contrarily, F-3.5s 
after PEG plasma polymerization (F-3.5s+PEG), display the highest amount of drug 
released (Fig. 5).  
3.3.   Influence of plasma treatment on the antibacterial activity 
To evaluate the antibacterial activity of ampicillin-loaded PP with the different plasma 
treatments, the inhibition areas were tested for Staphylococcus aureus and Escherichia 
coli (see Additional material 1). The method used allows a relatively quick and easy 
qualitative method to determine antibacterial activity of diffusible antimicrobial agents 
on treated textile materials [34, 35]. Control samples without ampicillin did not show 
any inhibition area for UT, F plasma-treated or PEG-coated PP meshes. 
Untreated PP mesh presents an inhibition area for S. aureus of 45.03 ± 8.29 mm2 and no 
statistically significant differences were found among samples loaded with ampicillin 
with any of the treatments performed, confirming that antibacterial activity was 
preserved.  
In the case of antibacterial activity of the ampicillin-loaded PP meshes tested for E. coli. 
an increase of the inhibition area for all the plasma-treated PP meshes was recorded 
with respect to the UT mesh, from 402.6 ± 26.4 mm2 for untreated mesh to 752.4 ± 45.4 
mm2 for 3.5 s F-plasma treatment (F-3.5s). This behavior can be related with the 
increased loading of ampicillin of the PP meshes obtained after functionalizing plasma 
treatment. After PEG plasma polymerization of the F-plasma treated PP meshes, this 
increased activity against E. coli is conserved.  
3.4.   Influence of plasma treatment on topographical properties 
The topographical modifications introduced by F and/or PP plasma treatments have 
been investigated by SEM and AFM and the results are presented respectively in Fig. 6 
and Fig. 7. 
Fig. 7a reveals that the surface of UT PP is mainly flat showing a limited nanometric 
roughness, with an average roughness (RRMS) of 5.8 nm. In the case of F plasma 
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treatment, important changes in roughness are observed with the longer plasma 
treatment time studied. While short plasma treatment times (F-0.35s) do not affect 
significantly the roughness regarding the UT sample, the value of mean roughness 
(RRSM) increased from RRSM= 5.8 nm for the untreated PP mesh to RRSM= 20.3 nm for 
the sample treated for F-1.75s with plasma and RRSM= 18.3 nm for the F-3.5s plasma 
treatment (Fig. 7b).  
3.5. Influence of the plasma treatment on in vitro cell behavior 
The different surface chemistry, roughness, or ampicillin loading of the different PP 
meshes obtained by plasma treatments may have effects on processes related to the first 
step of host cell recruitment and infiltration during tissue repair. Thus, the influence of 
the F-plasma treatments, the ampicillin loading and the plasma PEG-coating has been 
evaluated on cell proliferation, chemotactic response, cell adhesion and morphology.  
3.5.1. Influence on the cell proliferation 
Influence of the initial preparation of the PP meshes has been studied on the growth 
medium used for the cell cultures. Thus, cell proliferation was quantified using THP1 
monocytes (Fig. 8a) and NIH/3T3 fibroblasts (Fig. 8b) in contact with conditioned 
culture media generated from the different PP meshes to evaluate the biological 
response as an indicator of cellular properties of these materials.  
The F-3.5s plasma treatment of the PP meshes does not alter significantly the THP-1 
monocytes proliferation after 24 hours and slightly slows down the cell proliferation 
over 48 hours-assay without presenting cytotoxic effects (Fig. 8a). Incorporation of 
Ampicillin (AMP) does not alter monocyte proliferation, while the combination of 
plasma with drug loading (F-0.35+AMP) shows the greatest inhibition in THP1 cell 
growth. The PEG plasma coating limits this cytotoxicity, recovering to slightly better 
cell growth values, particularly after 72 h.  
No significant changes were observed in the cell growth of NIH-3T3 fibroblasts with 
reference to control at 24h with any of the treatments evaluated (Fig. 8b). However, 
after 48 h samples with plasma PEG coating displayed a slight inhibition (between 12 
and 30% depending on the treatment sequence) in cell proliferation with respect to the 
UT ones.  
Although some treatments attenuate cell proliferation, no meshes induced cell death 
above that observed with the control, as quantified by means of an exclusion test with 
Trypan Blue (Additional material 2), and as also observed at the morphological level, 
where there is no suggestive change indicating cell death (Additional material 3). 
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3.5.2. Chemotactic response 
Chemotactic response has been studied for the different PP meshes using NIH-3T3 
fibroblasts cultured in 2% FBS growth medium (non-proliferation conditions), and the 
results are presented in Fig. 8c. These results were obtained using non-proliferative 
conditions to eliminate interference caused by the influence of the treatments on the cell 
proliferation. 
Both UT PP meshes as well as the plasma-treated, ampicillin-loaded and PEG plasma-
coated ones (F-3.5s+AMP+PEG) did not induce chemotaxis, showing similar levels to 
the negative control. All other treatments evaluated on PP meshes induced cell 
chemotaxis. The most significant difference was observed with the media conditioned 
by the ampicillin-loaded PP mesh, whether with or without previous F plasma 
treatment. 
3.5.3. Influence on the cell adhesion 
Unlike the previous cellular assays, cells were also cultured and incubated in direct 
contact with the PP materials to evaluate the influence of the PP mesh surface 
modification on the cell adhesion and morphology, using NIH-3T3 fibroblasts.  
The cell adhesion on the F plasma-treated PP fibre surface and on UT+AMP-loaded 
ones decreased compared to what occurred in UT meshes, as can be observed in Fig. 9. 
In addition, fibroblasts adhered on F-3.5s PP fibres presented a more elongated 
morphology with respect to those attached on the UT PP.  
On the contrary, the F plasma treatment prior to AMP loading returned the adhesion and 
cell morphology to levels observed with UT PP. The same behavior - although more 
scattered - is observed with the ampicillin-loaded PP meshes submitted to a subsequent 
PEG plasma-coating. The samples combining all treatments (F-3.5s+AMP+PEG) 
maintained cell adhesion levels as the UT meshes, although with a more round and 
compact cell morphology.   
4. DISCUSSION
Given their good biocompatibility and mechanical properties, PP meshes are well 
established materials in the surgical repair of pathologies such as hernia. Hernia repair 
surgeries account for more than 1 million each year in the USA [36, 37].  The variety of 
meshes commonly used for hernia repair cover a range of polymer compositions, pore 
sizes, etc. the biocompatibility of which is determined by the extent of the patient’s 
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response to the implanted foreign body, as well as by the material characteristics of the 
mesh [38]. In the present study a macroporous polypropylene mesh currently employed 
in clinics was selected due to its medium weight which would allow better precision in 
recording drug loadings and release. Engelsman et al. [37] reviewed in 2007 a large 
number of clinical studies on infection rates of abdominal wall implants; surgery site 
infection rates for PP meshes range from 2 to >5% [37-44]. Although the prevalence of 
infections is low, the burden associated therein justifies seeking for suitable ways to 
deliver antibiotics locally during the surgery. This would avoid the prophylactic 
systemic administration often performed prior/post-surgery. In this work, a dry 
technology (plasma) modifying only the first nanometres of the surface of the PP 
meshes without altering its mechanical properties is investigated as a novel way for 
incorporating high amounts of antibiotics and maintaining the biological surface 
properties of the materials. Two different plasma processes have been investigated here: 
plasma functionalization and plasma polymerization.  
Plasma functionalization (F) with air at atmospheric pressure showed time-dependant 
effects, both regarding chemical modification and topographical changes (Figs. 2, 6, 7 
and Tables 1, 2).  For instance, the treatment rendered the hydrophobic PP surface 
hydrophilic, dropping contact angle from 120º down to 25º (Fig. 2). This was related in 
part to surface cleaning of hydrocarbon contaminants, but mainly due to grafting of 
Oxygen moieties on the surface (Tables 1, 2). As shown by XPS, since the 
polypropylene structure does not include oxygen atoms in its formula (CH2=CH-CH3), 
it can be observed that a small percentage of Si is present on the UT fibre surface that 
can be attributed to some adsorbed contamination from silicone-containing compounds 
that can also justify the presence of oxygen. The increase of oxygen moieties can be 
attributed to a functionalization process of the fibre surface, while the reduction of 
silicon comes from the elimination of the remaining surfactants on the fibre surface 
from the initial washing of the PP fabrics.  
In general, UT PP fibres present a smooth surface (Fig. 6 and 7), as also shown in 
previous works [45, 46]. It can be observed that F-plasma treatment progressively 
increases the roughness of the surface, where nano-bumps appear. Similar effects were 
also described in a previous study on the modification of surface properties of PP films 
using glow discharge air plasma [47]. In that work, the surface roughness of the PP film 
increased after 2–10 min of plasma treatment and similar protrusions to those of the 
present work appear. In their case, for long plasma treatment times (10-20 min) the 
protruding spikes got flattened due to continued etching.  
The particular morphology of the nanostructures created by F plasma treatment on the 
PP surface does not directly correspond to etching of the polymer - as recorded with 
other polymers [23, 48] -, but agrees to more complex mechanisms related to polymer 
degradation. In fact, as shown in previous works [49-51], different mechanisms are 
taking place on the amorphous regions of the polymer; Combined etching processes, 
photo oxidation and thermal oxidation. The energy transferred to the polymer thermally 
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and from UV-VIS by the F plasma employed acts as a reaction initiator on the weakest 
regions of the polymer (ie. amorphous regions in between spherulites) which is then 
continued and enhanced by the presence of O and N radicals, as well as by the highly 
reactive O3 also present in the plasma.  
On loading these PP meshes with ampicillin a significant increase was recorded 
following F plasma treatments. Short treatment times (0.35-1.75 s) showed a 2-fold 
increase which can be attributed to the improved surface wettability, while longer times 
(3.5-7 s) loaded even higher amounts, up to 60%, corresponding to 3-fold the weight 
percentage loaded by the UT PP. In this case, in addition to the improved wettability 
after F plasma treatment due to the grafting of new C-O bonds, the major specific 
surface area given by the higher roughness implies a higher availability of bonding sites 
(through H-bonds) regarding the loading of the drug, in this case ampicillin.  
Plasma polymerization using Tetraglyme as monomer led to obtaining thin layers of 
PEG-like polymer on the surface of PP. This was shown by contact angle (Fig. 2) and 
XPS results, where the decomposition of the C1s peak (Table 2) revealed that 4 different 
carbon bindings [52] can be found on the PEG and F-3.5s+PEG PP samples, in contrast 
to only 2 in the UT or F-plasma treated ones. The ether peak is indicative of the PEG 
character of the coating, and can be related to the fragmentation process during the 
plasma polymerization [53-55].  
The contact angle values obtained here were slightly lower than the ones found in the 
literature for PEG plasma layers obtained from different monomers [56-60]. However, 
previous works [61] depositing PEG on Titanium from the same Tetraglyme monomer 
and similar discharge characteristics obtained contact angles ranging between 10 and 
30º. In the present paper UT PP submitted to polymerization (PEG) yielded similar 
wettability (Fig. 2), with contact angle around 10º. When the sample had undergone a 
previous F plasma treatment (F-3.5s+PEG), the value decreased down to 0º, reflecting 
perfect wettability, probably related to the combined effects of functionalization and 
enhanced roughness. While plasma polymerization of the UT PP did not affect the 
topography, with a RRSM = 6.8 nm, the effect of plasma polymerization process on the 
surface topography of the F plasma-treated sample is enhanced by the plasma 
polymerization treatment (Fig. 9 e,f and 10 c,d). The roughness still increased up to 
RRSM = 30.2 nm and the patterns obtained reveal preferential etching processes are 
taking place simultaneously to the coating deposition, which lead to well defined nano-
rough patterns.  
The drug release pattern from the UT or F-3.5s plasma treated PP meshes was unaltered 
by the PEG plasma treatments (data not shown), which can possibly be explained by the 
thickness of the PEG layer. The thin layer of polymer obtained can be ascribed to the 
low vapour pressure of the monomer employed, tetraglyme, so in future works other 
PEG-forming monomers will be investigated to obtain thicker layers which may also 
help regulating the drug release [62-66]. Critically, the total amount of ampicillin 
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loaded on the F-plasma treated materials is much higher than without the plasma 
treatment (nearly three-fold), and is related to higher released amounts (around 10 mg) 
from the F-3.5s and F-3.5s+PEG meshes, which may be very beneficial in views of 
local treatment. The antibacterial activity of the antibiotic released was conserved 
unaltered by the plasma treatments perfomed (Supplementary material 1). The 
Minimum Inhibitory Concentration (MIC) of Staphylococcus Aureus is much lower 
than that of Escherichia coli (MICSA 7] << MICEColi = 2-
[68]), which explains that in the former all samples overcome MIC and display the same 
inhibition areas, while in the latter the untreated sample has lower inhibition area than 
the rest of plasma treated samples with double and threefold times loading. Our 
approach differs from other works seeking antibacterial activity from textiles where 
plasma coatings are employed to prevent the release of the antibacterial agent (ie. Silver 
nanoparticles) to the surrounding media [69,70].  
PEG coatings for biomedical devices are intended to be non-toxic, antifouling and to 
show a decrease on the bacterial and cell adhesion. When the effects of mesh-
conditioned media on cell proliferation and viability were compared (Fig. 8 a and b), 
those coming from either AMP or F-3.5s plasma-treated meshes did not induce 
significant changes, while conditioned medium from plasma polymerization treated 
meshes (PEG) inhibited cell growth at levels close to cytoxicity (in accordance with the 
ISO10993). The Trypan blue exclusion test (Additional material 2) ruled out any 
cytotoxic effect and under phase contrast microscope no cell morphological alterations 
nor cell damage was observed (see Additional material 3). These data provided 
evidence that the inhibition of cell proliferation in cells cultured with PEG-treated 
media was the result of a cytostatic effect rather than a cytotoxic mechanism. Junge et 
al. [71] reported good matching between the in vitro cytotoxicity and the in vivo 
biocompatibility of polyvinylidenfluoride (PVDF) meshes evaluated for infection 
prophylaxis by plasma-induced graft polymerization of polyacrylic acid. In close 
parallelism to our work, they also incorporated an antibiotic to the abdominal meshes 
and employed plasma processes for the surface modification. However their approach 
where the plasma-induced coating was aimed at providing grafting sites for the 
gentamicin. This is opposite to our case, where the PEG-coating obtained by plasma 
polymerization is carried out after ampicillin loading to confer the meshes with suitable 
biocompatibility.   
One of the known techniques to eliminate surface “fouling” (or the random and 
unlimited adsorption of proteins to a surface has been the use of PEG-like surfaces, 
which have been prepared different methods, among which plasma deposition of 
tetraglyme [72,73]. These surface modifications not only avoid the unlimited adsorption 
of proteins, they also reduce monocyte, platelet and fibroblast adhesion in vitro [73-76]. 
The specific mechanism of how our PEG surfaces affect cell proliferation (and allowed 
cells to attach to their surface as well) remain unclear. Very few studies have addressed 
this specific issue; however, findings from in vitro studies suggest that these kind of 
surfaces are able to activate serum proteins present in the media such as the complement 
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system through mechanisms that are still unclear [77]. We might think that other 
proteins able to modulate cell proliferation and present in the cell culture media could 
be modified by these surfaces. Moreover, previous reports suggest that despite 
displaying excellent non-adhesive properties in vitro, PEG coatings seem to have severe 
limitations in certain longer-term applications, such as the loss of their non-fouling 
character together with the presence of a high number of adherent inflammatory cells 
after long term in in vitro conditions [78, 79] or in vivo implantation [80]. This 
unexpected response has been ascribed to the oxidative degradation of PEG surfaces, 
which in our study could explain the anti-proliferative effects by hypothetically 
dissolved elements in the growth media and the observation of a substantial number of 
adhered cells after culturing them in direct contact with the meshes.  
A polymer device should be able to provide a temporary scaffold that stimulates 
appropriate cellular and extracellular events that eventually improve wound healing 
[81]. In particular, in vivo mesh implantation is associated with increased cell 
recruitment, gelatinolytic activity, and neovasculogenesis, a host tissue response that 
dampens in a time-dependent manner [81, 82]. Within this context, the regulation of 
mobilility and recruitment of cells by chemotaxis are essential for recellularization and 
tissue regeneration.  
Regarding our PP meshes, ampicillin-loaded meshes both untreated and F plasma-
treated significantly stimulated in vitro NIH/3T3 migration exceeding that of the rest of 
surfaces, which may be related to the higher amount of ampicillin released into the 
medium by these two meshes compared with the ampicillin-loaded PEG-treated mesh. 
Dose-dependent effects of beta-lactams on several biological functions of eukariote 
cells have long been known [83], including the activation of chemotaxis in 
inflammatory cells [84, 85]. Again, F-plasma treated ampicillin-loaded PEG-treated PP 
meshes (F-3.5s+AMP+PEG) did not elicit the same effect, but maintained the slight 
migratory effects observed with the untreated PP fibres leading us to conclude that the 
combination of these three treatments allowed maintaining the same chemotactic 
behavior of the PP fibres, thus justifying the relevance of the entire conditioning of the 
PP meshes by plasma processing. 
Cell adhesion to extracellular matrix is another critical process that provides mechanical 
support and biochemical signals modulating tissue homeostasis and repair. In an 
analogous fashion, the surface properties of materials regulate cellular responses such as 
cell adhesion. The evidence of the lower cell adhesion in the F plasma-treated mesh 
(Fig. 9) emphasizes the predominance of the surface chemistry above the modification 
of the surface topography on the effects on cell behavior. Indeed, although higher 
roughness and improved wettability in these meshes can significantly influence cell 
adhesion and morphology – which was altered, with cells showing more elongated 
morphology, the increase in the surface amount of O-based chemical groups by means 
of plasma functionalization may have affected cell adhesion the opposite way, reducing 
it. It is well-known that ether groups are effective repelling cells and proteins and the 
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increase of CO groups from 2.28% on the surface of the untreated PP mesh to 6.80% on 
3.5 s F-plasma treated PP mesh (Table 2) could explain this decrease in cell adhesion 
[74]. Similarly, untreated AMP loaded meshes displayed low cell adhesion. 
Nevertheless, all of the PEG-coated PP meshes tended to recover cell adhesion to values 
close to the UT ones. Although the percentage of CO groups is similar and even higher 
than in F-plasma, other groups are found on the surface of the coated samples, such as 
ketone and carboxyl which surely play a role on the cell adhesion. Although the 
mechanisms are not yet clear, this is in line with previous works of Buxadera et al. [61] 
showing that tetraglyme plasma-deposited coatings in very similar conditions on Ti did 
not significantly affect fibroblast adhesion while showing antifouling and low bacterial 
adhesion properties. These results point out the suitable biocompatibility of the novel 
materials designed in here, and open the door for evaluating tissue integration in vivo in 
future studies.  
The effects observed are summarized in Fig. 10. Thus, the combined treatment 
presented here (F-3.5s+AMP+PEG) allows the design of PP meshes with much higher 
AMP loadings and maintaining essentially unchanged fibroblast properties such as 
chemotaxis or adhesion with respect to UT meshes. This is highly desirable as these PP 
meshes have shown good clinical behavior and may contribute to improving patient 
comfort (through the local treatment, avoiding systemic antibiotic administration) and 
avoiding infections (thus decreasing economic burden).  
5. CONCLUSIONS
In this work, two different plasma processes (Plasma Functionalization and Plasma 
Polymerization) are employed in a novel approach to design PP meshes for the 
prophylaxis and local treatment of infections in hernia repair. Plasma functionalization 
at atmospheric pressure has been used to modify PP fibre surfaces at a nanometric level, 
by functionalizing the surface with polar oxygen groups. These are related to a 
progressive increase of wettability as well as surface roughness dependent on the 
exposure time. The chemical and morphological changes produced on the surface of PP 
fibres allowed a better availability of bonding sites for subsequent attachment of 
molecules are related to nearly 3-fold higher ampicillin loading in the PP meshes after 
only 3.5 s of F plasma treatment. However, these treatments alone were related with 
lower fibroblast adhesion, altered morphology and enhanced chemotaxis. Thus, the 
plasma-functionalized PP meshes containing high antibiotic loads were plasma-coated 
to obtain a nanometric polyethylene glycol-like layer (F-3.5s+AMP+PEG) that allowed 
combining higher AMP loadings and maintaining essentially unchanged fibroblast 
properties such as chemotaxis or adhesion with respect to UT meshes. As determined by 
bacterial assays with E. coli and S. aureus, the biological activity of the antibiotic was 
conserved after the different plasma treatments performed on the fabrics. 
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Table 1: Surface elemental composition and atomic ratios of PP meshes with different 
functionalizing (F) plasma or polymerizing (PEG) plasma treatments. 
Samples 
UT F-1.75s  F-3.5s  UT+PEG F-3.5s+PEG  
C1s 
84.0 84.2 79.7 83.8 81.2 
O1s 
10.0 13.4 18.5 15.5 18.8 
N1s 
0.3 0.1 0.7 0.1 <0.1 
Si2p 
5.8 2.3 1.1 0.6 <0.1 
O/C 
0.12 0.16 0.23 0.18 0.23 
Table 1: Fraction of carbon functional groups from high-resolution C1s XPS peaks for 
untreated and plasma treated samples and of the same after PEG-coating for 1 hour by 
plasma polymerization. 
Samples 
Relative chemical bonds (%) 
284.76 eV 286.16 eV 287.22 eV 288.66 eV 
C-C, C-H C-O C=O COOH 
UT 97.72 2.28 - - 
F-1.75s  96.74 3.26 - - 
F-3.5s  93.20 6.80 - - 
UT+PEG 86.80 6.64 2.29 4.27 
F-3.5s+PEG 84.66 7.14 4.56 3.64 
Table 1: Surface elemental composition and atomic ratios of PP meshes with different 
functionalizing (F) plasma or polymerizing (PEG) plasma treatments. 
Samples 
UT F-1.75s  F-3.5s  UT+PEG F-3.5s+PEG  
C1s 
84.0 84.2 79.7 83.8 81.2 
O1s 
10.0 13.4 18.5 15.5 18.8 
N1s 
0.3 0.1 0.7 0.1 <0.1 
Si2p 
5.8 2.3 1.1 0.6 <0.1 
O/C 











Table 1: Surface elemental composition and atomic ratios of PP meshes with different 
functionalizing (F) plasma or polymerizing (PEG) plasma treatments. 
Table 2: Fraction of carbon functional groups from high-resolution C1s XPS peaks for 
untreated and plasma treated samples and of the same after PEG-coating for 1 hour by 
plasma polymerization. 
Figure Captions 
Figure 1. Experimental design for the design of enhanced surgical PP meshes through 
plasma functionalization treatments, antibiotic loading and plasma polymerization of 
PEG coatings, with detail of sample codes.   
Figure 2. Water static contact angle as a function of plasma treatment time. 
Figure 3. C1s high-resolution XPS spectra of UT (a) and F-3.5s plasma-treated PP 
meshes and their homologues after PEG plasma coating (c) PEG and (d) F-3.5s+PEG. 
Figure 4. Ampicillin loading percentage of the PP meshes as a function of F air plasma 
treatment time. Different symbols indicate statistically significant differences (p<0.05). 
Figure 5. Cumulative ampicillin release percentage after 4h and ampicillin amount 
released from UT, F - plasma-treated and PEG-plasma coated PP meshes. Different 
symbols indicate statistically significant differences (p<0.05). 
Figure 6. Scanning Electron Micrographs of UT (a), plasma-treated PP mesh F-1.75s (b) 
F-3.5s (c), F-7s (d) and after PEG plasma coating: UT+PEG (e) F-3.5s+PEG (f), with 
the corresponding magnification of (e) and (f). 
Figure 7. AFM topography (top images) of the UT (a), F-3.5s plasma-treated (b) PP 
meshes, and after PEG plasma coating: UT+PEG (c) and F-3.5s+PEG (d), with the 
respective 3D reconstitutions of the fibre surface (bottom images). 
Figure 8. Effects of cell growth media conditioned by the ampicillin-loaded or unloaded 
PP meshes with different surface treatments on cell proliferation and migration. (a) 
Assessment of cell number by cell counting in THP1 monocytes. Each time point is 
expressed as a relative value to time 0. (b) NIH3T3 fibroblast cell growth evaluated by 
crystal violet staining. Time points are expressed as relative values to cells cultured with 
DMEM / 2%FBS (negative control). (c) Assessment of NIH/3T3 migration index in in 
vitro transwell assay. Values represent the average and bars represent S.D of two 
independent experiments carried out each time in triplicates.  Different symbols indicate 
statistically significant differences (p<0.05). 
2 
Figure 9. Adhesion and cell morphology assessment of NIH/3T3 fibroblasts cultured on 
a) UT, b) F-3.5 s plasma-treated, c) AMP ampicillin-loaded, d) F-3.5s+AMP plasma-
treated and ampicillin-loaded, e) AMP+PEG ampicillin-loaded and PEG-coated, f) F-
3.5s+AMP+PEG plasma-treated, ampicillin-loaded and PEG-coated PP meshes. Cells 
were cultured for 24h and images of crystal violet staining  were captured at 16X 
magnification; scale bar = 100 μm. Graph shows a box plot depicting  the adherent cell 
number per unit surface (10 fields per condition). Values represent two independent 
experiments carried out each time in triplicates.* indicates statistically significant 
differences vs UT sample.  
Figure 10. Summary of the effects of the different plasma treatments performed to PP 
fibres on the adsorption of drugs and on the cell adhesion and morphology. 



